Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-10

Clinical Trial Update: The Efficacy and Safety of Topical Vitamin D Drop on Meibomian Gland Function in Patients With Meibomian Gland Dysfunction [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating the efficacy and safety of topical vitamin D drops for improving Meibomian Gland Function in Meibomian Gland Dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical Vitamin D Drop

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Meibomian Gland Dysfunction | Phase 2, Phase 3 | Status: UNKNOWN